# The role of cannabinoid ligands in neurodegenerative diseases: emerging anti-inflammatory, immunomodulation and disease-modifying perspectives. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/the-role-of-cannabinoid-ligands-in-neurodegenerative-diseases-emerging-anti/ > **Published:** 2026-04-28T22:02:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T16:05:21-04:00 > **Clinical Summary:** Neurodegenerative diseases (NDs) constitute a growing global health burden driven by population aging and remain without disease-modifying therapies. Althoug... --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic Journal Pharmacological research Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). Clinicians monitoring evidence in this area should review the source material. Clinical Summary Neurodegenerative diseases (NDs) constitute a growing global health burden driven by population aging and remain without disease-modifying therapies. Although chronic neuroinflammation and aberrant protein aggregation are widely recognized as shared pathological hallmarks of major NDs – including Alzheimer’s, Parkinson’s, Huntington’s diseases and [multiple sclerosis](https://cedclinic.com/respiratory-function-exercise-therapy-ms/) – the causal relationships linking immunoinflammatory signaling to neurodegenerative progression remain contentious. Therapeutic strategies targeting neuroinflammation have thus far yielded limited clinical success, underscoring the need for mechanistically grounded and context-specific interventions. The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) (ECS) is a key regulator of synaptic function, glial activity, and immune homeostasis in the central nervous system (CNS), and its dysregulation has been consistently reported in neurodegenerative settings. However, ECS alterations across NDs are heterogeneous and often disease- and stage-dependent, Dr. Caplan’s Take “This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.” Clinical Perspective 🧠 Clinicians should review this item in the context of their current practice and patient population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20role%20of%20cannabinoid%20ligands%20in%20neurodegenerative%20diseases%3A%20emerging%20anti-inflammatory%2C%20immunomod...%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fthe-role-of-cannabinoid-ligands-in-neurodegenerative-diseases-emerging-anti%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fthe-role-of-cannabinoid-ligands-in-neurodegenerative-diseases-emerging-anti%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20role%20of%20cannabinoid%20ligands%20in%20neurodegenerative%20diseases%3A%20emerging%20anti-inflammatory%2C%20immunomod...%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fthe-role-of-cannabinoid-ligands-in-neurodegenerative-diseases-emerging-anti%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41937092/](https://pubmed.ncbi.nlm.nih.gov/41937092/) Table of Contents - [FAQ](#FAQ)[What do Alzheimer’s, Parkinson’s, and similar diseases have in common biologically?](#What_do_Alzheimer8217s_Parkinson8217s_and_similar_diseases_have_in_common_biologically) - [Have treatments targeting brain inflammation worked for neurodegenerative diseases?](#Have_treatments_targeting_brain_inflammation_worked_for_neurodegenerative_diseases) - [What role does the endocannabinoid system play in the brain?](#What_role_does_the_endocannabinoid_system_play_in_the_brain) - [Related](#Related) ## FAQ ### What do Alzheimer’s, Parkinson’s, and similar diseases have in common biologically? Chronic neuroinflammation and abnormal protein aggregation are widely recognized as shared hallmarks of major neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases and [multiple sclerosis](https://cedclinic.com/respiratory-function-exercise-therapy-ms/). However, the summary notes that the causal links between immune and inflammatory signaling and the progression of neurodegeneration remain contentious. ### Have treatments targeting brain inflammation worked for neurodegenerative diseases? So far, with limited success. The summary states that therapeutic strategies targeting neuroinflammation have yielded limited clinical success. It says this underscores the need for interventions that are mechanistically grounded and context-specific. ### What role does the endocannabinoid system play in the brain? The [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) is a key regulator of synaptic function, glial activity, and immune balance in the central nervous system. Its dysregulation has been consistently reported in neurodegenerative settings, but these changes are heterogeneous across diseases and often depend on the specific disease and its stage. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).